Clin2
NCT04362826Possibly a fitRecruiting

Trial tests a probiotic to change gut microbes in breast cancer

Breast Cancer

Part of Cancer, Skin clinical trials.

This study gives a probiotic to see whether it safely changes the gut’s bacteria and fungi (your “microbiome”) in people with breast cancer. The researchers want to learn if this shift in gut microbes might support breast cancer treatment or health during care.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
100 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You have been diagnosed with invasive ductal or invasive lobular breast cancer
  • Your breast tumor is at least 1.0 cm in size
  • Your body mass index (BMI) is between 18.5 and 29.9
  • If you can become pregnant, you will use approved birth control and have a negative pregnancy test
  • You will avoid unpasteurized fermented foods and keep your usual diet and activity the same (except no probiotics) during the study
  • You can understand the study and sign written informed consent

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07605728Recruiting· Phase 2
Probiotics to ease stomach problems from breast cancer treatment

This trial tests whether a special probiotic supplement (good bacteria) can reduce belly discomfort caused by abemaciclib, a hormone therapy drug for early breast cancer. You would take the supplement alongside your cancer treatment to see if it helps with stomach side effects.

Taipei
NCT06039644Recruiting
Probiotics for breast cancer patients on chemotherapy

This trial tests whether taking a probiotic supplement can help breast cancer patients going through chemotherapy. If you are between 20 and 80 years old, have stage I-III breast cancer, and are receiving certain chemo drugs, this study may be for you.

Taipei
NCT07653698Not yet recruiting
Gut bacteria and weight loss in breast cancer home care

This study looks at how gut bacteria relate to weight loss and muscle wasting (cachexia) in women with breast cancer who receive care at home. It may help doctors better understand and treat these symptoms.

NCT06768931Recruiting· Phase 2
Combination therapy before surgery for triple-negative breast cancer

This trial tests adding an immunotherapy drug to standard chemotherapy before surgery for triple-negative breast cancer. The goal is to see if this combination works better than chemotherapy alone.

Lanzhou, Gansu
NCT07253168Not yet recruiting
Study of gut bacteria in breast cancer surgery

This study looks at how bacteria in the gut and tumor affect breast cancer in women having surgery. The goal is to learn more about the cancer to improve treatment in the future.

NCT07144826Recruiting· Early Phase 1
Probiotic for Gut and Vaginal Health in Ovarian Cancer Chemotherapy

This trial tests whether taking a probiotic supplement can help balance the bacteria in your gut and vagina while you undergo chemotherapy for advanced ovarian cancer. It aims to see if this could improve your treatment experience or outcomes.

Columbus, Ohio

Hear when a new Breast cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.